NCT05402397View on ClinicalTrials.gov

Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies

PHASE4CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

January 1, 2024

Conditions

Uric Acid Nephropathy

Interventions

DRUG

Losartan Potassium

Patients will receive losartan potassium for 30 days.

Trial Locations (1)

1417

HGNPE, CABA

All Listed Sponsors

lead

Hospital General de Niños Pedro de Elizalde

OTHER